NEW YORK (GenomeWeb News) – Astute Medical said today that it has raised $6.2 million in a Series A round of financing led by De Novo Ventures.
 
San Diego-based Astute is developing protein biomarker-based tests for the rapid diagnosis and risk assessment of patients with hospital-acquired infections. The firm said it would use the funds from the first round of financing for research and development of the biomarkers.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.